Juniper Genomics
PrivateLast Round
Seed
Jun 26, 2025
Total Funding Raised
$4.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Juniper Genomics operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Seed round in June 2025.
Juniper Genomics is a biotechnology company that provides an advanced embryo screening test for in-vitro fertilization (IVF) using whole-genome and transcriptome sequencing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Juniper Genomics Comparables
Compare Juniper Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Orchid | 87% | |
| Genomic Prediction | 85% | |
| Progenesis | 81% |
For institutional investors. Book with your work email.
Juniper Genomics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Juniper Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Company Ventures | Seed |
| Company Ventures | Seed |
| Blue Collective | Seed |
| Velocity | Seed |
| InnoSpark Ventures | Seed |
| Amboy Street Ventures | Seed |
| FundRx | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 124% MoM, reaching 3.7K.
- Jun 20, 2026
Monthly visitors increased 44% MoM.
For institutional investors. Book with your work email.
Juniper Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Juniper Genomics's valuation, stock price, and market status.
Is Juniper Genomics a public or private company?
Juniper Genomics is a private company.
What is the current stock price of Juniper Genomics?
Juniper Genomics is a private company, so its shares have no public market price. Caplight tracks Juniper Genomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Juniper Genomics worth (valuation)?
Valuation information for Juniper Genomics is not publicly available.
Can I buy Juniper Genomics stock?
Juniper Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Juniper Genomics's last funding round?
Juniper Genomics's most recent funding round was Seed on June 26, 2025.
Who are the main investors in Juniper Genomics?
Key investors in Juniper Genomics include Company Ventures, Company Ventures.
Will Juniper Genomics IPO soon?
No public IPO plans have been announced for Juniper Genomics.
How can I track Juniper Genomics secondary market activity?
Caplight tracks bids, offers, and trades in Juniper Genomics's shares on secondary markets.